Craft

WuXi AppTec

Stock Price

¥38.7

2024-07-03

Market Capitalization

¥106 B

2024-07-03

Revenue

¥40 B

FY, 2023

WuXi AppTec Summary

Company Summary

Overview
WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies. It offers drug discovery, pre-clinical development, clinical processes research, synthetic chemistry, biology, medicinal chemistry, analytical chemistry, toxicology, bioanalysis, and testing services. The company serves the pharmaceutical, biotech, and medical device industries.
Type
Public
Status
Active
Founded
2000
HQ
Shanghai, CN | view all locations
Website
https://www.wuxiapptec.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

Operating MetricsView all

Active Customers

6K
2.6%

H1, 2023

New Customers

600
7.7%

H1, 2023

Scientists and Researchers

38K
3.3%

H1, 2023

LocationsView all

30 locations detected

  • Shanghai, Shanghai Shi HQ

    China

    288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area

  • Austin, TX

    United States

    5301 Southwest Parkway, Suite 100

  • Cranbury, NJ

    United States

    6 Cedarbrook Dr

  • Hayward, CA

    United States

    3912 Trust Way

  • Marietta, GA

    United States

    1265 Kennestone Cir

  • Mendota Heights, MN

    United States

    2540 Executive Dr

and 24 others

WuXi AppTec Financials

Summary Financials

Revenue (Q1, 2024)
¥7.9B
Gross profit (Q1, 2024)
¥3.0B
Net income (Q1, 2024)
¥2.0B
Cash (Q1, 2024)
¥15.7B
EBIT (Q1, 2024)
¥1.9B
Enterprise value
$97.4B

Footer menu